InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neurovascular Devices/Interventional Neurology Market By Products (aneurysm coiling & embolization devices (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents, Embolic Protection, Balloon Catheters), Support Devices (Microcatheters And Guidewires), and Neurothrombectomy Devices (Clot Retrievals, Suction & Aspiration, Snares)), End-Users (Hospitals & Surgical Centers, Ambulatory Care Centers, And Research Laboratories & Academic Institutes) – Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by InsightAce Analytic, the global Neurovascular Devices or Interventional Neurology Market Size is valued at 3.29 Billion in 2024 and is predicted to reach 7.70 Billion by the year 2034 at a 9.0 % CAGR during the forecast period for 2025-2034.


Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1345


Major market players operating in the Neurovascular Devices/Interventional Neurology market include Medtronic PLC (Ireland), Stryker Corporation (US), Terumo Corporation (Japan), Johnson & Johnson (US), Microport Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation (US), Penumbra, Inc. (US), Balt (France), Perflow Medical (Israel), Phenox GmbH (Germany), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co. Ltd (Japan), Sensome (France), Acandis GmbH (Germany), Medikit Co. Ltd (Japan), Straub Medical AG (Switzerland), Imperative Care (US), Lepu Medical (China), MicroVention, Inc. (US), Mizuho Medical (Japan), Cerus Endovascular (US), Peter Lazic GmBH (Germany), Spartan Micro (US), Emboflu (Switzerland), AngioDynamics (US), Microbot Medical Inc. (US) among others.

Over the past three decades, neurovascular diseases have consistently ranked among the leading causes of mortality worldwide. A combination of genetic predisposition, underlying medical conditions, and lifestyle factors significantly contribute to the risk of developing such disorders. Neurovascular devices are instrumental in the treatment of conditions affecting the blood vessels that supply oxygenated blood to the brain.


Curious about this latest version of the report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1345


The global Neurovascular Devices (Interventional Neurology) market is primarily driven by several key factors, including the growing incidence of stroke, rapid advancements in microguidewire technology, increasing demand for minimally invasive neurosurgical procedures, and a rise in neurovascular surgical interventions. Additionally, favorable medical reimbursement policies for neurovascular treatments and increased government spending on healthcare infrastructure are contributing to market expansion. The rising prevalence of neurological conditions such as stroke, epilepsy, cerebral aneurysms, arteriovenous malformations (AVM), and carotid artery stenosis continues to fuel the demand for neurovascular devices. According to the World Health Organization (WHO), approximately 15 million individuals globally experience a stroke each year, with 5 million fatalities and another 5 million cases resulting in permanent disability—imposing significant social and economic burdens.

North America led the global market with a major revenue share in 2021. This can be linked to enhanced healthcare infrastructure, rising prevalence of chronic neurological illnesses & neurological disorders and improving healthcare infrastructure.


Add our site to Google Preferred Sources for quality content :
https://google.com/preferences/source?q=insightaceanalytic.com


Key developments in the market:
• In April 2022, Integer Holdings Corporation announced the acquisition of Connemara Biomedical Holdings Teoranta, comprising its operating companies Aran Biomedical and Proxy Biomedical. The partnership with Aran further strengthens Integer's capacity to offer full solutions for complicated delivery and treatment devices in high-growth cardiovascular areas such as structural heart, neurovascular, peripheral vascular, and endovascular, as well as general surgery.
• In March 2022, Cerus Endovascular Ltd. announced that it had gained 510(k) approval from the U.S. Food and Drug Administration (FDA) for its 027 micro-catheters, which are available in two lengths, increasing its product range, which currently includes the 021 micro-catheter platforms. The business anticipates submitting both sizes for CE Marking under the new EU Medical Devices Regulation. Cerus Endovascular also announced the expansion of the Contour Neurovascular System's available sizes. The newly developed additional sizes (3mm, 18mm, and 22mm) will enable the treatment of aneurysms up to 18mm in diameter.
• In December 2021, Microbot Medical Inc. (US) collaborated with Stryker, a leading global medical technology company. The Microbot Medical will collaborate with Stryker's Neurovascular division to integrate its neurovascular instruments with Microbot's LIBERTY Robotic System to develop the world's first dedicated robotic procedural kits for use in specific neurovascular procedures.
• In September 2021, Medtronic plc (Ireland), received CE Mark approval for its radial artery access portfolio, including the Rist 079 Radial Access Guide Catheter and Rist Radial Access Selective Catheter. The Rist 079 Radial Access Guide Catheter is the first catheter designed explicitly for the unique demands of accessing the neuro vasculature through the radial artery versus access through the transfemoral artery.
• In December 2020, Terumo Corporation (Japan) launched the WEB Embolization System, an intravascular aneurysm treatment device, in Japan. With this commercial launch, Terumo provides new treatment options for brain aneurysm cases that were difficult to treat in currently approved methods.


For More Customization @
https://www.insightaceanalytic.com/customisation/1345


Market Segments
Global Neurovascular Devices/Interventional Neurology Market, by Products, 2025-2034 (Value US$ Mn) and Volume (No. of Units)
• Aneurysm Coiling & Embolization Devices
o Embolic Coils
 Bare Detachable Coils
 Coated Detachable Coils
o Flow Diversion Devices
o Liquid Embolic Agents
• Cerebral Balloon Angioplasty & Stenting Systems
o Carotid Artery Stents
o Embolic Protection Devices
o Balloon Catheters
• Support Devices
o Microcatheters
o Guidewires
• Neurothrombectomy devices
o Clot Retrievals
o Suction & Aspiration Devices
o Snares
Global Neurovascular Devices/Interventional Neurology Market, by End-Users, 2025-2034 (Value US$ Mn) and Volume (No. of Units)
• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes
Global Neurovascular Devices/Interventional Neurology Market, by Region, 2025-2034 (Value US$ Mn) and Volume (No. of Units)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neurovascular Devices/Interventional Neurology Market, by Country, 2025-2034 (Value US$ Mn) and Volume (No. of Units)
• U.S.
• Canada
Europe Neurovascular Devices/Interventional Neurology Market, by Country, 2025-2034 (Value US$ Mn) and Volume (No. of Units)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neurovascular Devices/Interventional Neurology Market, by Country, 2025-2034 (Value US$ Mn) and Volume (No. of Units)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neurovascular Devices/Interventional Neurology Market, by Country, 2025-2034 (Value US$ Mn) and Volume (No. of Units)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neurovascular Devices/Interventional Neurology Market, by Country, 2025-2034 (Value US$ Mn) and Volume (No. of Units)
• GCC Countries
• South Africa
• Rest of Middle East & Africa


Get More Information:
https://www.insightaceanalytic.com/report/global-neurovascular-devices-or-interventional-neurology-market/1345


About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
[email protected]
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: [email protected]
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/